TD Cowen Sticks to Their Hold Rating for Milestone Pharmaceuticals (MIST)
TD Cowen analyst Ritu Baral maintained a Hold rating on Milestone Pharmaceuticals (MIST – Research Report) yesterday. The company's shares closed last Friday at $1.22.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Baral is a 3-star analyst with an average return of 2.5% and a 39.31% success rate. Baral covers the Healthcare sector, focusing on stocks such as Sarepta Therapeutics, Alnylam Pharma, and Madrigal Pharmaceuticals.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Milestone Pharmaceuticals with a $7.50 average price target.
MIST market cap is currently $65.23M and has a P/E ratio of -1.47.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Why Intel's (INTC) Comeback Might Happen Sooner Than Expected
As an investor who's watched Intel's (INTC) challenges unfold over the past few years, I'm genuinely excited about Lip-Bu Tan stepping in as CEO. Tan's approach is both bold and strategic—the exact combination Intel desperately needs. He's already making aggressive moves to restructure the company, ramp up investments in manufacturing and AI, and put the foundry business at the forefront. Despite the plethora of both internal and external turmoil, INTC stock has managed to post a flat first six months of 2025. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Tan is steering Intel not only to reclaim its former dominance but potentially to exceed it. I'm bullish on the outlook—but realistic, too—knowing it will take time for Intel to solidify its AI foothold and deliver meaningful returns in the years ahead. Since taking the helm as CEO in March 2025, Tan has wasted no time launching a significant restructuring to slash layers of middle management that have long bogged down Intel's innovation and decision-making. The plan calls for reducing the workforce by about 20%—a tough but necessary move to streamline the organization and accelerate its agility. This isn't just about trimming costs; it's about making Intel leaner and faster. The company aims to reduce operating expenses to around $17 billion by FY 2025. While layoffs are never easy, Intel has grown bloated compared to rivals and now faces an intensely competitive market where survival—and success—demand swift action. As things stand, Intel lags behind its sector peers on several key metrics. I'm confident that a leaner Intel will be sharper, faster, and better positioned to innovate boldly and prove its strength to the competition. However, Tan must handle the workforce cuts with care, focusing on retaining key talent and maintaining morale through a strong, principled leadership approach. Arguably, Tan's boldest move is his unwavering commitment to Intel's advanced manufacturing, especially the cutting-edge 18A node (1.8nm) technology. Set to power Intel's Panther Lake CPUs by late 2025, this breakthrough could dramatically boost energy efficiency and performance, potentially allowing Intel to finally compete toe-to-toe with giants like TSMC (TSM) and Samsung (SSNLF). On the foundry front, Intel Foundry Services (IFS) is gaining serious momentum. High-profile deals—most notably with Microsoft (MSFT)—to utilize Intel's 18A process could transform Intel into a fierce contender in the foundry market. Securing a few more marquee contracts from the likes of Nvidia (NVDA) or Apple (AAPL) would be a game-changer, sparking a significant surge in investor confidence and substantially lifting Intel's valuation. That said, delays in the massive Ohio manufacturing facility, now pushed back to around 2030, raise concerns about capacity constraints and potential missed opportunities if chip demand suddenly spikes. Intel's challenge going forward will be striking the right balance in capital allocation and maintaining a nimble leadership team ready to seize emerging market opportunities quickly. Looking ahead to 2028, Intel's financial health will largely depend on how well it executes its strategy. Analysts project relatively flat to slightly declining revenue in FY 2025, hovering between $50 billion and $53 billion, with a modest recovery expected afterward. Earnings per share of around $0.30 for 2025 seem reasonable, given the current margin pressures. In my base-case outlook, Intel modestly rebounds to about $60 billion in revenue by 2028, with earnings per share approaching $3.00. This scenario would support a share price rising to around $40 from today's $20—a steady but unspectacular return over three years, especially with the dividend still cut during the turnaround. However, in a bull-case scenario, if Intel secures major foundry contracts and capitalizes on strong AI-driven demand, earnings per share could reach $5.00 by 2028, pushing shares into the $70 to $90 range. Conversely, if Intel falters in execution, revenue stagnates, and growth stalls, the stock could remain stuck in the $20s with limited upside potential. Intel is facing significant challenges, and execution, especially talent retention and deployment, will be critical. Any delays or yield issues with the 18A node could undermine confidence and push foundry customers toward competitors like TSMC. Additionally, Intel faces intense competition in chip design from Nvidia (NVDA) and AMD (AMD). Still, I believe the opportunities outweigh the risks. Despite dominant rivals, Intel's valuation remains attractively low, with a price-to-sales ratio under 2, compared to TSMC's 8.5, leaving plenty of room for multiple expansion as earnings momentum improves and investor sentiment turns positive. History shows that undervalued companies staging a comeback can deliver compelling investment stories. When it comes to INTC, most of Wall Street is sitting on the fence. Intel carries a consensus Hold rating, backed by two Buys, 25 Holds, and four Sells. INTC's average stock price target is $21.29, suggesting roughly 6.5% upside over the next year. Although this suggests it may be premature to expect significant gains, investors who buy now and hold through the stagnation phase could reap rewards if sentiment improves—truly a case of being better off being early than too late. There's no guarantee Intel will pull off a complete turnaround, but the company is clearly taking bold steps to tackle years of bloat, strategic drift, and technological lag. Still, winning over a competitive market dominated by entrenched giants won't be easy—it will require grit from management, sharp strategic vision, and a bit of luck. That said, for portfolios seeking value-driven upside, a modest stake in Intel could be a worthwhile investment. I'm cautiously optimistic. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Archer Aviation Stock (ACHR) Soars on Strong Q1 and Upcoming UAE Launch
Archer Aviation (ACHR) has seen its stock jump over 47% this week since it delivered a commanding performance in the first quarter of 2025, beating earnings expectations while positioning itself for the historic milestone of becoming one of the first companies to launch commercial electric air taxi operations with its eVTOL aircraft. The results showcase a company successfully navigating the complex path from aviation startup to operational reality. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter The future of flying cars is finally here. I have been, and continue to be, extremely bullish on this opportunity. While ACHR stock is approaching its all-time high, the sky is literally the limit for this nascent technology. The company's Q1 2025 financial results exceeded Wall Street's expectations across key metrics. As a startup, the company has been in cash-burning mode for some time, yet for the quarter, Archer's net loss improved dramatically by falling 20% year-over-year to $93.4 million from $116.5 million in Q1 2024. This beat demonstrates the company's improving cost management as it approaches commercialization. Still, the company ended the quarter with $1 billion in cash and cash equivalents. This war chest increased by $196 million from year-end 2024, thanks to successful capital raises that gave the company a substantial financial runway to launch its first aircraft later this year. Archer reported an earnings per share loss of just $0.17, significantly better than analyst estimates ranging from $0.22 to $0.28 per share. Looking ahead, management projects a Q2 adjusted EBITDA loss between $100 million and $120 million, reflecting continued strategic investments in manufacturing, certification, and international expansion. Archer has moved beyond the drawing board and into serious production mode. The company began manufacturing conforming Midnight aircraft as planned, targeting up to 10 units in 2025. By year-end, Archer aims to produce two aircraft per month, as it ramps to a pace supporting meaningful commercial operations. The company has also made strategic acquisitions to strengthen its manufacturing capabilities, including a composites manufacturing facility, in a move to control key aspects of its supply chain while still leveraging established aerospace suppliers for other components. This hybrid approach differentiates Archer from competitors like Joby Aviation (JOBY), which has pursued a more vertically integrated strategy. Archer's decision to work with proven Tier 1 aerospace suppliers is intended to reduce risk and accelerate time to market. Archer has assembled an impressive group of strategic partners, such as its collaboration with Palantir Technologies (PLTR). The partnership with the technology company aims to develop next-gen artificial intelligence systems for aviation. Its partnership with United Airlines (UAL) represents a significant opportunity in the lucrative U.S. market, with plans for an air taxi network connecting Manhattan to major airports. Meanwhile, the exclusive partnership with Anduril Industries opens defense market opportunities, including hybrid VTOL aircraft for military applications. Defense contracts could accelerate cash generation as they don't require the same FAA certification process as commercial aircraft. A significant milestone for Archer remains its imminent commercial launch in the United Arab Emirates. The first piloted Midnight aircraft is expected to be delivered to the UAE this summer, with commercial passenger flights beginning by the fourth quarter of 2025. The company's 'Launch Edition' program represents a carefully crafted strategy for entering international markets with local partners who understand regional dynamics. For example, Abu Dhabi Aviation will serve as Archer's first commercial customer, with Ethiopian Airlines lined up to follow shortly thereafter. This approach allows Archer to provide comprehensive support, including aircraft, pilots, technicians, and software, while building operational expertise in real-world conditions. Beyond the UAE, Archer is actively pursuing opportunities across multiple continents. The company has identified partnerships and potential operations in India, Japan, Singapore, Australia, Saudi Arabia, and South Korea. A recent agreement with Korea's KakaoMobility targets commercial operations in South Korea by 2026. Despite the positive momentum, Archer faces significant challenges that are common to the eVTOL industry. The most critical requirement remains FAA Type Certification for its Midnight aircraft. While Archer has secured important certifications like Part 135 for air carrier operations, full type certification remains pending and could influence commercial launch timelines in the U.S. Further, competition is intensifying. Well-funded rivals like Joby Aviation are racing to capture similar markets, and early commercial success will likely depend on execution, timing, and the ability to scale operations efficiently. Archer Aviation is rated a Strong Buy based on the most recent recommendations of seven analysts (6 Buy, 1 Hold). The average 12-month price target for ACHR stock is $12.83, representing a ~5% downside from current levels. Despite the downside price targets, most analysts remain bullish about Archer's prospects post earnings. For instance, Cantor Fitzgerald analyst Andres Sheppard maintains a bullish stance with a $13 price target, citing the company's strong position in advanced air mobility and valuable partnerships. Needham's Chris Pierce and H.C. Wainwright's Amit Dayal both maintain Buy ratings with price targets of $13 and $12.50, respectively. They cite Archer's diversified approach, combining civil and defense markets, and its substantial cash position, which provides flexibility during the critical commercialization phase. We're witnessing a pivotal moment in aviation history, and Archer is emerging as a frontrunner. With a solid financial foundation, rapidly advancing manufacturing capabilities, and commercial operations just around the corner, the company is well-positioned to spearhead the eVTOL movement. Its upcoming launch in the UAE will be a critical milestone—one that could prove not only the Midnight aircraft's technical readiness but also the broader operational and economic case for eVTOLs. A successful rollout could open the door to global expansion and reinforce confidence in the market's long-term potential. I remain bullish on Archer's outlook. Its leadership position makes it an attractive opportunity for investors seeking exposure to the fast-developing urban air mobility space. Disclaimer & DisclosureReport an Issue Sign in to access your portfolio
Business Insider
6 hours ago
- Business Insider
Barclays Keeps Their Sell Rating on Wizz Air Holdings (WIZZ)
Barclays analyst Andrew Lobbenberg maintained a Sell rating on Wizz Air Holdings (WIZZ – Research Report) today and set a price target of £9.00. The company's shares closed last Friday at p1,174.00. Confident Investing Starts Here: Lobbenberg covers the Industrials sector, focusing on stocks such as Deutsche Lufthansa, International Consolidated Airlines, and Aegean Airlines. According to TipRanks, Lobbenberg has an average return of 2.0% and a 50.84% success rate on recommended stocks. In addition to Barclays, Wizz Air Holdings also received a Sell from Jefferies's Jaina Mistry in a report issued on June 5. However, on June 6, J.P. Morgan maintained a Hold rating on Wizz Air Holdings (LSE: WIZZ). The company has a one-year high of p2,548.00 and a one-year low of p1,135.00. Currently, Wizz Air Holdings has an average volume of 617.2K. Based on the recent corporate insider activity of 24 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of WIZZ in relation to earlier this year.
